Cullinan Therapeutics, Inc. (CGEM) short interest & options flow
NASDAQCullinan Therapeutics heads into its November 13 earnings call with a stock down 29% on the week and analysts who haven't blinked, a gap that makes this one of the sharper valuation disconnects in small-cap biotech right now. The price action is the most striking fact of the week. CGEM closed at $11.23 on November 10, off 4% on the day and 29% over the past five sessions, extending…
- Market cap
- $729M
- Next earnings
- 13 Nov 2026
Key data as of 11 Nov 2026

CGEM news and analysis
RSSNo long-form analysis yet for CGEM. Pulse alerts and the live data picture are available on ORTEX.
Open CGEM on ORTEX →Want the live picture for CGEM?
Short interest updated daily, real-time options flow, analyst consensus deltas, 13F positioning, ORTEX Alpha signals, and every article ORTEX publishes for CGEM — free to start on ORTEX.
Sign up for free →Open CGEM on ORTEX